| 29.4 |
117.6 |
GO:0060901 |
regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 20.0 |
120.1 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 19.9 |
19.9 |
GO:0002543 |
activation of blood coagulation via clotting cascade(GO:0002543) |
| 9.6 |
115.4 |
GO:0086073 |
bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 9.6 |
28.7 |
GO:0070563 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 9.3 |
9.3 |
GO:0010482 |
epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 8.7 |
61.2 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 8.2 |
65.4 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 8.1 |
24.2 |
GO:1903452 |
regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 8.0 |
8.0 |
GO:1900190 |
biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 7.6 |
22.8 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 7.6 |
22.8 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 7.0 |
27.9 |
GO:0010979 |
regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 6.7 |
60.6 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 6.2 |
62.0 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 6.0 |
223.0 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 6.0 |
36.2 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
| 6.0 |
18.1 |
GO:0002581 |
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 5.9 |
17.7 |
GO:1904316 |
positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 5.6 |
39.1 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 5.5 |
44.2 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 5.5 |
11.0 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 5.4 |
65.3 |
GO:0035986 |
senescence-associated heterochromatin focus assembly(GO:0035986) |
| 5.4 |
5.4 |
GO:0097102 |
endothelial tip cell fate specification(GO:0097102) |
| 5.3 |
15.8 |
GO:0002586 |
regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 5.2 |
20.7 |
GO:1901994 |
negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 5.1 |
15.3 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) negative regulation of chloride transport(GO:2001226) |
| 5.0 |
35.3 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 5.0 |
15.0 |
GO:0002025 |
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 4.9 |
14.6 |
GO:1903609 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 4.6 |
4.6 |
GO:0009912 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 4.5 |
112.6 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 4.4 |
4.4 |
GO:0031077 |
post-embryonic camera-type eye development(GO:0031077) |
| 4.4 |
31.1 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 4.3 |
17.3 |
GO:0042223 |
response to molecule of fungal origin(GO:0002238) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) cellular response to molecule of fungal origin(GO:0071226) |
| 4.3 |
17.3 |
GO:1903382 |
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 4.3 |
25.7 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 4.3 |
25.5 |
GO:0010752 |
regulation of cGMP-mediated signaling(GO:0010752) |
| 4.1 |
57.6 |
GO:0035290 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 4.1 |
73.8 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 4.0 |
20.2 |
GO:0042539 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 4.0 |
12.0 |
GO:2000452 |
CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 3.9 |
7.9 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 3.8 |
15.3 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 3.8 |
18.8 |
GO:0045659 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 3.7 |
7.5 |
GO:0006670 |
sphingosine metabolic process(GO:0006670) |
| 3.7 |
18.6 |
GO:0003409 |
optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 3.7 |
11.1 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 3.6 |
7.3 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 3.6 |
10.7 |
GO:0061193 |
sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 3.5 |
24.8 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 3.5 |
17.7 |
GO:0015688 |
response to mycotoxin(GO:0010046) iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 3.5 |
21.2 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 3.5 |
72.7 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 3.3 |
10.0 |
GO:0061713 |
neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 3.3 |
33.2 |
GO:1903764 |
regulation of potassium ion export across plasma membrane(GO:1903764) |
| 3.2 |
19.3 |
GO:1904219 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 3.1 |
27.9 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 3.1 |
74.0 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 3.1 |
18.5 |
GO:1900827 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 3.1 |
162.8 |
GO:0043616 |
keratinocyte proliferation(GO:0043616) |
| 3.0 |
27.3 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 3.0 |
12.0 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 3.0 |
9.0 |
GO:0071301 |
cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 2.9 |
43.8 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 2.9 |
14.3 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 2.8 |
14.0 |
GO:0002906 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 2.8 |
16.8 |
GO:0060268 |
negative regulation of respiratory burst(GO:0060268) |
| 2.7 |
30.1 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 2.7 |
8.0 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 2.7 |
2.7 |
GO:0030099 |
myeloid cell differentiation(GO:0030099) |
| 2.7 |
98.4 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 2.6 |
7.9 |
GO:0043317 |
negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 2.6 |
10.5 |
GO:1905123 |
regulation of glucosylceramidase activity(GO:1905123) |
| 2.6 |
52.4 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 2.6 |
7.8 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 2.6 |
10.4 |
GO:0060474 |
positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 2.4 |
4.9 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 2.4 |
4.8 |
GO:0033025 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 2.4 |
7.2 |
GO:0048627 |
myoblast development(GO:0048627) |
| 2.4 |
23.8 |
GO:0098881 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 2.4 |
7.1 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 2.3 |
18.5 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 2.2 |
38.2 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 2.2 |
2.2 |
GO:0090272 |
negative regulation of fibroblast growth factor production(GO:0090272) |
| 2.2 |
40.0 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 2.2 |
15.3 |
GO:0002786 |
regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
| 2.2 |
6.5 |
GO:0032904 |
viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 2.2 |
4.3 |
GO:0009608 |
response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 2.1 |
10.6 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 2.1 |
10.6 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 2.1 |
31.4 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 2.1 |
31.2 |
GO:0015884 |
folic acid transport(GO:0015884) |
| 2.0 |
16.2 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 2.0 |
14.1 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 2.0 |
15.8 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 1.9 |
3.9 |
GO:0035627 |
ceramide transport(GO:0035627) |
| 1.9 |
7.5 |
GO:0010983 |
positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 1.9 |
5.6 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 1.8 |
5.5 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 1.8 |
12.9 |
GO:1902164 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 1.8 |
5.5 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 1.8 |
27.5 |
GO:0032119 |
sequestering of zinc ion(GO:0032119) |
| 1.8 |
23.8 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 1.8 |
14.4 |
GO:0051546 |
keratinocyte migration(GO:0051546) |
| 1.8 |
9.0 |
GO:0072674 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 1.8 |
32.1 |
GO:0015816 |
glycine transport(GO:0015816) |
| 1.8 |
3.6 |
GO:0032796 |
uropod organization(GO:0032796) protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 1.8 |
3.5 |
GO:0071450 |
cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 1.8 |
21.2 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
| 1.7 |
7.0 |
GO:0060574 |
intestinal epithelial cell maturation(GO:0060574) |
| 1.7 |
20.6 |
GO:2000582 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 1.7 |
15.2 |
GO:2000660 |
negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 1.7 |
5.0 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 1.6 |
4.9 |
GO:0031204 |
posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 1.6 |
8.1 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 1.6 |
11.3 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 1.6 |
14.5 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 1.6 |
11.2 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 1.6 |
6.4 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 1.6 |
8.0 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 1.6 |
17.5 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 1.6 |
4.8 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 1.6 |
4.7 |
GO:0030070 |
insulin processing(GO:0030070) |
| 1.6 |
6.3 |
GO:1902962 |
regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 1.6 |
3.2 |
GO:0098868 |
endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
| 1.6 |
20.4 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 1.6 |
12.5 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 1.6 |
10.9 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 1.6 |
9.3 |
GO:0030336 |
negative regulation of cell migration(GO:0030336) |
| 1.5 |
30.8 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 1.5 |
1.5 |
GO:0002085 |
inhibition of neuroepithelial cell differentiation(GO:0002085) |
| 1.5 |
16.9 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 1.5 |
10.7 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 1.5 |
6.1 |
GO:1902544 |
regulation of DNA N-glycosylase activity(GO:1902544) |
| 1.5 |
6.0 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 1.5 |
13.5 |
GO:0071798 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 1.5 |
6.0 |
GO:0034721 |
histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 1.5 |
4.4 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 1.5 |
5.9 |
GO:1904116 |
response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 1.5 |
13.3 |
GO:0061370 |
testosterone biosynthetic process(GO:0061370) |
| 1.5 |
10.2 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 1.4 |
50.5 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 1.4 |
12.6 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 1.4 |
7.0 |
GO:1902951 |
negative regulation of dendritic spine maintenance(GO:1902951) |
| 1.4 |
12.5 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 1.4 |
27.6 |
GO:0090179 |
planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 1.4 |
15.0 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 1.4 |
5.4 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 1.4 |
5.4 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 1.4 |
10.8 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
| 1.3 |
8.1 |
GO:0033489 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 1.3 |
1.3 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 1.3 |
4.0 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 1.3 |
6.6 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 1.3 |
6.6 |
GO:1902904 |
negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 1.3 |
5.3 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 1.3 |
1.3 |
GO:0070831 |
basement membrane assembly(GO:0070831) |
| 1.3 |
6.5 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 1.3 |
14.3 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 1.3 |
33.7 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 1.3 |
6.5 |
GO:0007509 |
mesoderm migration involved in gastrulation(GO:0007509) |
| 1.3 |
3.8 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 1.3 |
114.1 |
GO:2000649 |
regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 1.3 |
5.1 |
GO:1901727 |
positive regulation of histone deacetylase activity(GO:1901727) |
| 1.3 |
5.0 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 1.3 |
12.6 |
GO:1904379 |
protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 1.3 |
2.5 |
GO:0042704 |
uterine wall breakdown(GO:0042704) |
| 1.2 |
5.0 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 1.2 |
3.7 |
GO:2000656 |
regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 1.2 |
17.4 |
GO:0032596 |
protein transport into membrane raft(GO:0032596) |
| 1.2 |
7.4 |
GO:0014004 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 1.2 |
7.4 |
GO:1900114 |
positive regulation of histone H3-K9 trimethylation(GO:1900114) |
| 1.2 |
3.7 |
GO:0046963 |
3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 1.2 |
4.9 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 1.2 |
20.6 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 1.2 |
3.6 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 1.2 |
6.0 |
GO:0035900 |
response to isolation stress(GO:0035900) |
| 1.2 |
4.8 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 1.2 |
19.2 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 1.2 |
32.1 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 1.2 |
38.0 |
GO:0050716 |
positive regulation of interleukin-1 secretion(GO:0050716) |
| 1.2 |
4.7 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) multi-organism catabolic process(GO:0044035) development involved in symbiotic interaction(GO:0044111) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 1.2 |
3.5 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 1.2 |
5.9 |
GO:0016129 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 1.2 |
9.4 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 1.2 |
2.3 |
GO:0042747 |
circadian sleep/wake cycle, REM sleep(GO:0042747) |
| 1.2 |
4.7 |
GO:0032489 |
regulation of Cdc42 protein signal transduction(GO:0032489) |
| 1.2 |
9.3 |
GO:1900625 |
regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 1.2 |
8.1 |
GO:0060633 |
negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
| 1.2 |
4.6 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 1.2 |
9.3 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 1.2 |
10.4 |
GO:0015677 |
copper ion import(GO:0015677) |
| 1.2 |
5.8 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 1.2 |
17.3 |
GO:0046520 |
sphingoid biosynthetic process(GO:0046520) |
| 1.1 |
8.0 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 1.1 |
3.4 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 1.1 |
5.7 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 1.1 |
12.5 |
GO:0098887 |
neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 1.1 |
10.1 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 1.1 |
32.6 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 1.1 |
1.1 |
GO:0090288 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) negative regulation of cellular response to growth factor stimulus(GO:0090288) |
| 1.1 |
7.5 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 1.1 |
6.4 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 1.1 |
4.2 |
GO:0044029 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 1.1 |
8.4 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 1.1 |
11.6 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 1.0 |
3.1 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 1.0 |
14.4 |
GO:0042473 |
outer ear morphogenesis(GO:0042473) |
| 1.0 |
12.3 |
GO:2000544 |
cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
| 1.0 |
4.1 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 1.0 |
2.0 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 1.0 |
2.0 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 1.0 |
12.0 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 1.0 |
3.9 |
GO:0099563 |
modification of synaptic structure(GO:0099563) |
| 1.0 |
11.7 |
GO:0031069 |
hair follicle morphogenesis(GO:0031069) |
| 1.0 |
17.6 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 1.0 |
3.9 |
GO:0061550 |
cranial ganglion development(GO:0061550) |
| 1.0 |
2.9 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 1.0 |
16.4 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 1.0 |
2.9 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.9 |
2.8 |
GO:0061485 |
memory T cell proliferation(GO:0061485) |
| 0.9 |
2.8 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.9 |
9.4 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.9 |
15.0 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.9 |
7.5 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.9 |
7.4 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.9 |
5.6 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.9 |
6.5 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.9 |
11.0 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.9 |
11.0 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.9 |
44.8 |
GO:0045022 |
early endosome to late endosome transport(GO:0045022) |
| 0.9 |
69.3 |
GO:0070830 |
bicellular tight junction assembly(GO:0070830) |
| 0.9 |
10.0 |
GO:0042354 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.9 |
13.4 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.9 |
2.7 |
GO:0031064 |
negative regulation of histone deacetylation(GO:0031064) |
| 0.9 |
2.7 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.9 |
5.4 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.9 |
15.1 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.9 |
7.1 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.9 |
13.1 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.9 |
5.2 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.9 |
6.1 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
| 0.9 |
0.9 |
GO:1904469 |
interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.9 |
2.6 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.9 |
18.0 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.9 |
6.0 |
GO:0090625 |
mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.9 |
8.5 |
GO:0033183 |
negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.9 |
4.3 |
GO:0090063 |
positive regulation of microtubule nucleation(GO:0090063) |
| 0.8 |
3.4 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.8 |
2.5 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.8 |
18.6 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.8 |
3.4 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.8 |
2.5 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.8 |
3.3 |
GO:1904180 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.8 |
1.6 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.8 |
4.1 |
GO:0002415 |
immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.8 |
6.6 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.8 |
6.6 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.8 |
19.6 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.8 |
5.6 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.8 |
3.2 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.8 |
4.8 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.8 |
3.2 |
GO:0006617 |
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.8 |
4.0 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.8 |
23.8 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.8 |
5.6 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.8 |
7.1 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.8 |
1.6 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 0.8 |
2.4 |
GO:0070898 |
RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.8 |
12.5 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.8 |
169.7 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.8 |
4.7 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.8 |
13.2 |
GO:0090175 |
Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
| 0.8 |
2.3 |
GO:0098884 |
postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.8 |
6.9 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) negative regulation of lamellipodium organization(GO:1902744) |
| 0.8 |
3.8 |
GO:0007178 |
transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0007178) |
| 0.8 |
2.3 |
GO:0043396 |
corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 0.8 |
6.1 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.8 |
2.3 |
GO:2000118 |
regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.8 |
2.3 |
GO:0071262 |
regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
| 0.8 |
2.3 |
GO:0007388 |
anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.8 |
6.0 |
GO:0051126 |
negative regulation of actin nucleation(GO:0051126) |
| 0.7 |
2.2 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.7 |
40.2 |
GO:0055078 |
sodium ion homeostasis(GO:0055078) |
| 0.7 |
7.4 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.7 |
2.2 |
GO:1903689 |
regulation of wound healing, spreading of epidermal cells(GO:1903689) |
| 0.7 |
22.7 |
GO:0030511 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.7 |
3.7 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.7 |
7.3 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.7 |
3.6 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.7 |
4.4 |
GO:1904823 |
pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.7 |
18.8 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.7 |
10.1 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.7 |
3.6 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.7 |
8.6 |
GO:0014894 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.7 |
8.6 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.7 |
12.8 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.7 |
11.4 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.7 |
3.5 |
GO:0006172 |
ADP biosynthetic process(GO:0006172) |
| 0.7 |
1.4 |
GO:1904783 |
positive regulation of NMDA glutamate receptor activity(GO:1904783) |
| 0.7 |
2.1 |
GO:0032355 |
response to estradiol(GO:0032355) |
| 0.7 |
4.2 |
GO:0072752 |
cellular response to rapamycin(GO:0072752) |
| 0.7 |
38.3 |
GO:0010812 |
negative regulation of cell-substrate adhesion(GO:0010812) |
| 0.7 |
1.4 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.7 |
2.7 |
GO:0042144 |
vacuole fusion, non-autophagic(GO:0042144) |
| 0.7 |
5.4 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.7 |
5.3 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.7 |
17.2 |
GO:1904776 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.7 |
5.3 |
GO:0072502 |
cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.7 |
2.0 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
| 0.7 |
2.6 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.7 |
2.6 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.7 |
3.3 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.7 |
3.3 |
GO:0070945 |
neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.6 |
2.6 |
GO:0098727 |
maintenance of cell number(GO:0098727) |
| 0.6 |
5.8 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.6 |
15.3 |
GO:0060004 |
reflex(GO:0060004) |
| 0.6 |
2.5 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.6 |
5.7 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.6 |
1.3 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) |
| 0.6 |
4.4 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.6 |
2.5 |
GO:0045732 |
positive regulation of protein catabolic process(GO:0045732) |
| 0.6 |
5.0 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.6 |
5.0 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.6 |
1.2 |
GO:0071907 |
determination of pancreatic left/right asymmetry(GO:0035469) determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.6 |
12.9 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.6 |
3.1 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.6 |
0.6 |
GO:0060538 |
skeletal muscle organ development(GO:0060538) |
| 0.6 |
3.1 |
GO:0003068 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.6 |
3.1 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.6 |
2.4 |
GO:0048842 |
positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.6 |
1.2 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.6 |
2.4 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.6 |
1.8 |
GO:1990922 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.6 |
9.0 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.6 |
1.8 |
GO:1905146 |
lysosomal protein catabolic process(GO:1905146) |
| 0.6 |
3.0 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.6 |
3.6 |
GO:0030073 |
insulin secretion(GO:0030073) |
| 0.6 |
5.9 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.6 |
1.8 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.6 |
1.8 |
GO:1903056 |
regulation of melanosome organization(GO:1903056) |
| 0.6 |
2.9 |
GO:0052027 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.6 |
4.7 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.6 |
10.5 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.6 |
7.0 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.6 |
8.6 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.6 |
2.3 |
GO:0072138 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.6 |
12.5 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 0.6 |
2.8 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.6 |
4.5 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.6 |
5.0 |
GO:0032606 |
regulation of type I interferon production(GO:0032479) type I interferon production(GO:0032606) |
| 0.6 |
2.2 |
GO:1900224 |
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.6 |
0.6 |
GO:0060734 |
regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.6 |
19.9 |
GO:0060512 |
prostate gland morphogenesis(GO:0060512) |
| 0.6 |
2.2 |
GO:0060151 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.5 |
1.1 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.5 |
6.0 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.5 |
1.6 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.5 |
1.6 |
GO:0035038 |
female pronucleus assembly(GO:0035038) |
| 0.5 |
2.7 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.5 |
3.3 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) |
| 0.5 |
14.6 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.5 |
3.3 |
GO:0034959 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.5 |
2.2 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.5 |
5.9 |
GO:0043297 |
apical junction assembly(GO:0043297) |
| 0.5 |
5.4 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.5 |
8.6 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.5 |
3.7 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.5 |
5.8 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) |
| 0.5 |
4.2 |
GO:1905232 |
cellular response to L-glutamate(GO:1905232) |
| 0.5 |
5.8 |
GO:0045836 |
positive regulation of meiotic nuclear division(GO:0045836) |
| 0.5 |
7.3 |
GO:0042738 |
exogenous drug catabolic process(GO:0042738) |
| 0.5 |
4.1 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.5 |
7.7 |
GO:0019441 |
tryptophan catabolic process to kynurenine(GO:0019441) |
| 0.5 |
10.7 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.5 |
5.1 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.5 |
6.1 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.5 |
0.5 |
GO:1904882 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.5 |
7.6 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.5 |
0.5 |
GO:1903902 |
positive regulation of viral life cycle(GO:1903902) |
| 0.5 |
2.5 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.5 |
0.5 |
GO:0016539 |
intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.5 |
2.5 |
GO:0006050 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.5 |
5.0 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.5 |
14.0 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.5 |
2.5 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.5 |
0.5 |
GO:0045218 |
cell-cell junction maintenance(GO:0045217) zonula adherens maintenance(GO:0045218) |
| 0.5 |
4.0 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.5 |
2.5 |
GO:0090155 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.5 |
2.5 |
GO:2000691 |
regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.5 |
1.0 |
GO:0002449 |
lymphocyte mediated immunity(GO:0002449) |
| 0.5 |
47.5 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.5 |
1.5 |
GO:0051155 |
positive regulation of striated muscle cell differentiation(GO:0051155) |
| 0.5 |
3.9 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.5 |
1.4 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.5 |
5.3 |
GO:0019896 |
axonal transport of mitochondrion(GO:0019896) |
| 0.5 |
1.9 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.5 |
2.9 |
GO:0072104 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.5 |
3.3 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.5 |
0.9 |
GO:0048864 |
stem cell development(GO:0048864) |
| 0.5 |
1.4 |
GO:0034402 |
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.5 |
1.9 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.5 |
1.8 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.5 |
17.4 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.5 |
4.5 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.5 |
2.7 |
GO:0001712 |
ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.4 |
5.8 |
GO:0090487 |
toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.4 |
11.2 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.4 |
0.9 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.4 |
4.5 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.4 |
27.0 |
GO:0050690 |
regulation of defense response to virus by virus(GO:0050690) |
| 0.4 |
0.9 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.4 |
4.4 |
GO:0031112 |
positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
| 0.4 |
9.2 |
GO:0098743 |
cell aggregation(GO:0098743) |
| 0.4 |
1.3 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.4 |
4.4 |
GO:0097201 |
negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.4 |
4.3 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.4 |
0.4 |
GO:0072387 |
flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.4 |
2.6 |
GO:0044245 |
polysaccharide digestion(GO:0044245) |
| 0.4 |
0.9 |
GO:0034165 |
positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.4 |
8.5 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.4 |
1.3 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.4 |
3.3 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.4 |
7.1 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.4 |
0.8 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.4 |
1.2 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.4 |
4.1 |
GO:0019720 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.4 |
1.2 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.4 |
4.9 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.4 |
1.2 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.4 |
3.3 |
GO:1902808 |
positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.4 |
1.2 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.4 |
4.0 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.4 |
2.4 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.4 |
4.0 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.4 |
3.2 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.4 |
4.8 |
GO:0099612 |
protein localization to axon(GO:0099612) |
| 0.4 |
7.1 |
GO:0036119 |
response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.4 |
2.4 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.4 |
6.6 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.4 |
3.5 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.4 |
4.3 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.4 |
3.9 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.4 |
1.9 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.4 |
1.5 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.4 |
6.4 |
GO:0090361 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.4 |
13.1 |
GO:0050855 |
regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.4 |
3.0 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.4 |
2.6 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.4 |
13.4 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.4 |
1.5 |
GO:0008050 |
female courtship behavior(GO:0008050) |
| 0.4 |
1.5 |
GO:0003356 |
regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
| 0.4 |
5.6 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.4 |
3.3 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.4 |
11.4 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.4 |
0.4 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.4 |
6.9 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.4 |
4.4 |
GO:0043306 |
positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.4 |
3.6 |
GO:0019627 |
urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 0.4 |
2.1 |
GO:0051304 |
chromosome separation(GO:0051304) |
| 0.4 |
1.8 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.4 |
0.7 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.4 |
14.1 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.4 |
12.3 |
GO:0006396 |
RNA processing(GO:0006396) |
| 0.4 |
32.3 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.4 |
2.1 |
GO:0060352 |
cell adhesion molecule production(GO:0060352) |
| 0.3 |
2.1 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.3 |
6.6 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.3 |
3.8 |
GO:0002084 |
protein depalmitoylation(GO:0002084) |
| 0.3 |
1.0 |
GO:0060839 |
endothelial cell fate commitment(GO:0060839) |
| 0.3 |
9.6 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.3 |
17.1 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
| 0.3 |
2.4 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
| 0.3 |
1.0 |
GO:1903721 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.3 |
1.7 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.3 |
3.7 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.3 |
5.6 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.3 |
5.3 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.3 |
4.6 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.3 |
1.3 |
GO:2000670 |
positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.3 |
15.4 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.3 |
2.3 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.3 |
1.0 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.3 |
1.0 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.3 |
15.3 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.3 |
5.5 |
GO:0043304 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.3 |
9.7 |
GO:0045124 |
regulation of bone resorption(GO:0045124) |
| 0.3 |
1.3 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.3 |
4.2 |
GO:0052697 |
flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.3 |
1.9 |
GO:0006295 |
nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.3 |
8.6 |
GO:0042481 |
regulation of odontogenesis(GO:0042481) |
| 0.3 |
3.8 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.3 |
8.2 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.3 |
4.4 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.3 |
21.3 |
GO:0015914 |
phospholipid transport(GO:0015914) |
| 0.3 |
2.2 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.3 |
0.9 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |
| 0.3 |
0.6 |
GO:0042214 |
terpene metabolic process(GO:0042214) |
| 0.3 |
0.6 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.3 |
0.9 |
GO:0032720 |
negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
| 0.3 |
1.2 |
GO:0061046 |
regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 0.3 |
1.8 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.3 |
2.1 |
GO:2000490 |
negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.3 |
11.4 |
GO:0050691 |
regulation of defense response to virus by host(GO:0050691) |
| 0.3 |
1.8 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.3 |
0.6 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.3 |
4.5 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.3 |
0.9 |
GO:0021551 |
central nervous system morphogenesis(GO:0021551) cardiac muscle tissue regeneration(GO:0061026) |
| 0.3 |
1.5 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.3 |
1.2 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.3 |
8.9 |
GO:0048012 |
hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.3 |
4.1 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.3 |
1.2 |
GO:0042471 |
ear morphogenesis(GO:0042471) |
| 0.3 |
5.3 |
GO:0050812 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.3 |
2.1 |
GO:0043606 |
histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.3 |
1.2 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.3 |
2.0 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.3 |
0.9 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.3 |
2.3 |
GO:1903826 |
arginine transmembrane transport(GO:1903826) |
| 0.3 |
4.4 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.3 |
0.9 |
GO:0060999 |
positive regulation of dendritic spine development(GO:0060999) |
| 0.3 |
3.4 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.3 |
1.7 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.3 |
1.1 |
GO:0010819 |
regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
| 0.3 |
5.0 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.3 |
3.4 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 |
2.8 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.3 |
7.2 |
GO:0030011 |
maintenance of cell polarity(GO:0030011) |
| 0.3 |
2.2 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.3 |
11.0 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.3 |
4.9 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.3 |
0.3 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.3 |
1.1 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.3 |
1.6 |
GO:1901909 |
diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.3 |
1.1 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.3 |
1.1 |
GO:1902527 |
positive regulation of protein monoubiquitination(GO:1902527) |
| 0.3 |
2.1 |
GO:0046959 |
habituation(GO:0046959) |
| 0.3 |
27.1 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.3 |
2.4 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.3 |
4.0 |
GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.3 |
2.6 |
GO:0002456 |
T cell mediated immunity(GO:0002456) |
| 0.3 |
0.8 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.3 |
1.0 |
GO:0010446 |
response to alkaline pH(GO:0010446) detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) cellular response to alkaline pH(GO:0071469) |
| 0.3 |
1.3 |
GO:0009233 |
menaquinone metabolic process(GO:0009233) |
| 0.3 |
1.0 |
GO:0021827 |
cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
| 0.3 |
8.1 |
GO:0001954 |
positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.3 |
5.3 |
GO:0006612 |
protein targeting to membrane(GO:0006612) |
| 0.3 |
2.0 |
GO:0035278 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.3 |
9.5 |
GO:0050918 |
positive chemotaxis(GO:0050918) |
| 0.2 |
1.0 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
| 0.2 |
1.7 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.2 |
1.0 |
GO:0097010 |
eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.2 |
2.2 |
GO:0071346 |
cellular response to interferon-gamma(GO:0071346) |
| 0.2 |
5.3 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.2 |
1.2 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.2 |
0.5 |
GO:0045720 |
negative regulation of integrin biosynthetic process(GO:0045720) |
| 0.2 |
0.5 |
GO:1900169 |
regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.2 |
2.6 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.2 |
1.7 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.2 |
1.9 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.2 |
1.4 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.2 |
4.0 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.2 |
1.9 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.2 |
2.5 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.2 |
5.3 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) |
| 0.2 |
2.5 |
GO:0035826 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.2 |
0.9 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.2 |
1.6 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.2 |
2.5 |
GO:0038066 |
p38MAPK cascade(GO:0038066) |
| 0.2 |
2.5 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.2 |
1.8 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.2 |
1.8 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.2 |
0.4 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.2 |
26.0 |
GO:0070268 |
cornification(GO:0070268) |
| 0.2 |
5.9 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.2 |
0.7 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 |
2.2 |
GO:0007045 |
cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
| 0.2 |
2.0 |
GO:0099500 |
synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.2 |
1.7 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 |
39.4 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.2 |
1.3 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.2 |
2.9 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.2 |
1.0 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.2 |
1.0 |
GO:0003366 |
cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.2 |
46.5 |
GO:0007266 |
Rho protein signal transduction(GO:0007266) |
| 0.2 |
1.6 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.2 |
5.3 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.2 |
0.4 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.2 |
4.5 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.2 |
0.8 |
GO:0000096 |
sulfur amino acid metabolic process(GO:0000096) sulfur amino acid biosynthetic process(GO:0000097) |
| 0.2 |
0.6 |
GO:0033132 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.2 |
5.2 |
GO:0045104 |
intermediate filament cytoskeleton organization(GO:0045104) |
| 0.2 |
1.8 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.2 |
2.4 |
GO:0001946 |
lymphangiogenesis(GO:0001946) |
| 0.2 |
0.6 |
GO:0060452 |
positive regulation of cardiac muscle contraction(GO:0060452) |
| 0.2 |
2.9 |
GO:0070571 |
negative regulation of neuron projection regeneration(GO:0070571) |
| 0.2 |
1.6 |
GO:0031054 |
pre-miRNA processing(GO:0031054) |
| 0.2 |
1.0 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.2 |
1.5 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.2 |
1.0 |
GO:1901889 |
negative regulation of cell junction assembly(GO:1901889) |
| 0.2 |
0.4 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.2 |
7.8 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.2 |
0.6 |
GO:0033561 |
regulation of water loss via skin(GO:0033561) |
| 0.2 |
1.1 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.2 |
1.1 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.2 |
3.0 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.2 |
1.7 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.2 |
4.4 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.2 |
4.0 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.2 |
1.5 |
GO:0043032 |
positive regulation of macrophage activation(GO:0043032) |
| 0.2 |
0.5 |
GO:0035995 |
detection of muscle stretch(GO:0035995) |
| 0.2 |
1.4 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.2 |
2.9 |
GO:0051092 |
positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.2 |
2.2 |
GO:0035984 |
response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.2 |
3.2 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.2 |
1.1 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.2 |
1.4 |
GO:0032402 |
melanosome transport(GO:0032402) |
| 0.2 |
2.9 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.2 |
0.9 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.2 |
0.9 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.2 |
1.5 |
GO:0071694 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.2 |
3.1 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.2 |
8.5 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.2 |
6.3 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
| 0.2 |
6.2 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.2 |
3.4 |
GO:0002335 |
mature B cell differentiation(GO:0002335) |
| 0.2 |
0.5 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.2 |
0.8 |
GO:0010863 |
positive regulation of phospholipase C activity(GO:0010863) |
| 0.2 |
0.7 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.2 |
0.5 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.2 |
5.5 |
GO:0022400 |
regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.2 |
2.8 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.2 |
12.5 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.2 |
1.8 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.2 |
1.9 |
GO:0044030 |
regulation of DNA methylation(GO:0044030) |
| 0.2 |
3.2 |
GO:0019722 |
calcium-mediated signaling(GO:0019722) |
| 0.2 |
1.3 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.2 |
9.1 |
GO:0098742 |
cell-cell adhesion via plasma-membrane adhesion molecules(GO:0098742) |
| 0.2 |
1.6 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.2 |
2.2 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.2 |
4.6 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.2 |
3.2 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.2 |
0.9 |
GO:2000535 |
regulation of entry of bacterium into host cell(GO:2000535) |
| 0.2 |
4.4 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.2 |
0.8 |
GO:0075509 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.2 |
2.9 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.2 |
4.8 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.1 |
1.0 |
GO:0002028 |
regulation of sodium ion transport(GO:0002028) |
| 0.1 |
5.1 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.1 |
1.2 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.1 |
0.1 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.1 |
0.9 |
GO:0052551 |
response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.1 |
0.7 |
GO:0030822 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.1 |
5.0 |
GO:0035307 |
positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
| 0.1 |
1.2 |
GO:0015825 |
L-serine transport(GO:0015825) |
| 0.1 |
0.3 |
GO:0007500 |
mesodermal cell fate determination(GO:0007500) |
| 0.1 |
0.7 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 |
0.6 |
GO:0032495 |
response to muramyl dipeptide(GO:0032495) |
| 0.1 |
5.1 |
GO:0051058 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.1 |
0.6 |
GO:1990785 |
response to water-immersion restraint stress(GO:1990785) |
| 0.1 |
4.5 |
GO:0006294 |
nucleotide-excision repair, preincision complex assembly(GO:0006294) |
| 0.1 |
2.1 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.1 |
1.7 |
GO:0070997 |
neuron death(GO:0070997) |
| 0.1 |
0.3 |
GO:0034086 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.1 |
1.4 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
2.7 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
2.4 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
16.6 |
GO:0002576 |
platelet degranulation(GO:0002576) |
| 0.1 |
0.9 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.1 |
1.8 |
GO:0042491 |
auditory receptor cell differentiation(GO:0042491) |
| 0.1 |
3.4 |
GO:0031958 |
corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.1 |
11.2 |
GO:0006903 |
vesicle targeting(GO:0006903) |
| 0.1 |
2.6 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.1 |
2.2 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.1 |
1.0 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 |
2.5 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.1 |
1.4 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 |
0.5 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.1 |
0.5 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.1 |
1.7 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.1 |
1.1 |
GO:0051497 |
negative regulation of stress fiber assembly(GO:0051497) |
| 0.1 |
1.1 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 |
1.2 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.1 |
0.9 |
GO:0015671 |
gas transport(GO:0015669) oxygen transport(GO:0015671) |
| 0.1 |
0.5 |
GO:0045586 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.1 |
0.6 |
GO:0070829 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 |
0.8 |
GO:0071850 |
mitotic cell cycle arrest(GO:0071850) |
| 0.1 |
1.3 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
5.7 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.1 |
1.6 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 |
3.1 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.1 |
0.4 |
GO:0010727 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
| 0.1 |
0.2 |
GO:0080154 |
regulation of fertilization(GO:0080154) |
| 0.1 |
1.1 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.1 |
0.3 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.1 |
1.2 |
GO:0021510 |
spinal cord development(GO:0021510) |
| 0.1 |
1.5 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.1 |
0.8 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.1 |
2.8 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 |
0.7 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.1 |
2.1 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 |
3.4 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
0.8 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.1 |
1.0 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.1 |
2.9 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.1 |
0.4 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 |
0.3 |
GO:0046946 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.1 |
0.3 |
GO:0045764 |
pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) positive regulation of cellular amino acid metabolic process(GO:0045764) thyroid-stimulating hormone secretion(GO:0070460) kidney field specification(GO:0072004) comma-shaped body morphogenesis(GO:0072049) metanephric comma-shaped body morphogenesis(GO:0072278) metanephric nephron tubule formation(GO:0072289) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) positive regulation of thyroid hormone generation(GO:2000611) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.1 |
0.4 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.1 |
0.5 |
GO:0090287 |
regulation of cellular response to growth factor stimulus(GO:0090287) |
| 0.1 |
0.7 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
0.9 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 |
1.0 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.1 |
2.5 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.1 |
11.8 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.1 |
0.9 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
2.2 |
GO:0090003 |
regulation of establishment of protein localization to plasma membrane(GO:0090003) |
| 0.1 |
0.3 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.1 |
0.5 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.1 |
15.9 |
GO:0016197 |
endosomal transport(GO:0016197) |
| 0.1 |
0.5 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
0.3 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
0.9 |
GO:0061684 |
chaperone-mediated autophagy(GO:0061684) |
| 0.1 |
4.0 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.1 |
3.6 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.1 |
1.3 |
GO:0046777 |
protein autophosphorylation(GO:0046777) |
| 0.1 |
2.1 |
GO:0007194 |
negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.1 |
0.1 |
GO:0090045 |
positive regulation of deacetylase activity(GO:0090045) |
| 0.1 |
0.3 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.1 |
0.5 |
GO:2000637 |
positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.1 |
0.2 |
GO:0045554 |
TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.1 |
0.8 |
GO:0032717 |
negative regulation of interleukin-8 production(GO:0032717) |
| 0.1 |
0.4 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.1 |
0.3 |
GO:0071715 |
icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
| 0.1 |
0.2 |
GO:0061371 |
determination of heart left/right asymmetry(GO:0061371) |
| 0.1 |
3.4 |
GO:0032755 |
positive regulation of interleukin-6 production(GO:0032755) |
| 0.1 |
0.9 |
GO:0030262 |
apoptotic nuclear changes(GO:0030262) |
| 0.1 |
1.3 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
3.8 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.1 |
1.2 |
GO:0006349 |
regulation of gene expression by genetic imprinting(GO:0006349) |
| 0.1 |
0.3 |
GO:0045209 |
MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.1 |
2.2 |
GO:1900739 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.1 |
0.3 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
| 0.1 |
0.9 |
GO:1902254 |
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
| 0.1 |
0.2 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 |
3.1 |
GO:0006892 |
post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.1 |
0.3 |
GO:0060281 |
regulation of oocyte development(GO:0060281) |
| 0.1 |
4.4 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.1 |
0.8 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 |
0.2 |
GO:0010518 |
positive regulation of phospholipase activity(GO:0010518) |
| 0.1 |
0.4 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.1 |
0.6 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.2 |
GO:1901052 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.1 |
0.2 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) |
| 0.1 |
0.2 |
GO:0060012 |
synaptic transmission, glycinergic(GO:0060012) |
| 0.1 |
0.9 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.1 |
0.2 |
GO:0032959 |
inositol trisphosphate biosynthetic process(GO:0032959) |
| 0.1 |
4.0 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.1 |
0.6 |
GO:0046465 |
dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.1 |
1.6 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 0.1 |
0.1 |
GO:0071284 |
cellular response to lead ion(GO:0071284) |
| 0.1 |
0.3 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 |
0.5 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.1 |
1.0 |
GO:0021904 |
dorsal/ventral neural tube patterning(GO:0021904) |
| 0.1 |
1.3 |
GO:0046426 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 |
0.5 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
0.1 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.0 |
3.3 |
GO:0009301 |
snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 |
0.2 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.0 |
1.3 |
GO:0050913 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) sensory perception of bitter taste(GO:0050913) |
| 0.0 |
1.1 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.0 |
1.5 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 |
0.3 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.0 |
0.1 |
GO:0046034 |
ATP metabolic process(GO:0046034) |
| 0.0 |
0.4 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
0.6 |
GO:2000169 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.0 |
0.8 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
0.3 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.0 |
0.5 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.0 |
0.2 |
GO:0098795 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.0 |
0.2 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.0 |
0.3 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.0 |
0.2 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.0 |
0.1 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.0 |
0.2 |
GO:1904749 |
regulation of protein localization to nucleolus(GO:1904749) |
| 0.0 |
0.2 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.0 |
0.6 |
GO:0061418 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.0 |
0.5 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.2 |
GO:0093001 |
glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.0 |
0.1 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.0 |
0.2 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.5 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.0 |
0.0 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.0 |
0.2 |
GO:0051251 |
positive regulation of cell activation(GO:0050867) positive regulation of lymphocyte activation(GO:0051251) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
1.0 |
GO:1901685 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 |
0.3 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.2 |
GO:0002087 |
regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.0 |
0.4 |
GO:2000181 |
negative regulation of angiogenesis(GO:0016525) negative regulation of blood vessel morphogenesis(GO:2000181) |
| 0.0 |
0.4 |
GO:0071377 |
response to glucagon(GO:0033762) cellular response to glucagon stimulus(GO:0071377) |
| 0.0 |
0.5 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 |
2.1 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.0 |
0.5 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.0 |
0.0 |
GO:0072139 |
B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) lung ciliated cell differentiation(GO:0061141) glomerular parietal epithelial cell differentiation(GO:0072139) |
| 0.0 |
0.1 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.0 |
0.4 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
0.1 |
GO:0043438 |
acetoacetic acid metabolic process(GO:0043438) |
| 0.0 |
0.2 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 |
0.2 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.0 |
0.8 |
GO:0048701 |
embryonic cranial skeleton morphogenesis(GO:0048701) |
| 0.0 |
0.4 |
GO:0043149 |
contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
| 0.0 |
0.1 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.0 |
0.3 |
GO:0060135 |
maternal process involved in female pregnancy(GO:0060135) |
| 0.0 |
0.2 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
0.4 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.0 |
0.2 |
GO:0016236 |
macroautophagy(GO:0016236) |
| 0.0 |
1.0 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
| 0.0 |
0.4 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.0 |
0.0 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) |
| 0.0 |
0.2 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.0 |
0.1 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.0 |
0.3 |
GO:0009791 |
post-embryonic development(GO:0009791) |
| 0.0 |
0.2 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.0 |
0.5 |
GO:0005980 |
glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 |
0.1 |
GO:0030166 |
proteoglycan biosynthetic process(GO:0030166) |
| 0.0 |
0.2 |
GO:0039694 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 |
0.3 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.0 |
GO:0002818 |
intracellular defense response(GO:0002818) |
| 0.0 |
0.2 |
GO:1900115 |
extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 |
0.1 |
GO:0048010 |
vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.0 |
1.0 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.0 |
0.1 |
GO:0001919 |
regulation of receptor recycling(GO:0001919) |
| 0.0 |
0.3 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 |
0.3 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.0 |
0.1 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.0 |
0.0 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |